A nurse is collecting data from a client prior to administering atenolol.
For which of the following findings should the nurse withhold the medication?

Choice A rationale:

Facial flushing. Facial flushing is not typically associated with atelectasis. Atelectasis is the collapse of a portion of the lung, which can lead to decreased oxygenation and respiratory distress but does not directly cause facial flushing. Flushing may be related to other factors such as fever or allergic reactions.

Choice B rationale:

Dry cough. A dry cough can be a common symptom of atelectasis. As the lung tissue collapses and airways become obstructed, it can lead to irritation and a dry, non-productive cough as the body attempts to clear the airway. So, a dry cough is an expected finding in a client with atelectasis.

Choice C rationale:

Decreasing respiratory rate. A decreasing respiratory rate is not typically associated with atelectasis. In fact, atelectasis often leads to an increased respiratory rate as the body tries to compensate for the reduced oxygen exchange. The patient may experience tachypnea (rapid breathing) as a result.

Choice D rationale:

Increasing dyspnea. Increasing dyspnea is a common and expected finding in a client with atelectasis. As lung tissue collapses and oxygen exchange is compromised, the patient will likely experience worsening shortness of breath. This is a concerning symptom and should be closely monitored, as it may indicate a need for intervention to improve lung expansion and oxygenation.

Choice D rationale:

The nurse should seek clarification for the prescribed medication Propranolol when caring for a client with an exacerbation of asthma. Propranolol is a non-selective beta-blocker, and its use can exacerbate bronchoconstriction and potentially worsen asthma symptoms. In patients with asthma, non-selective beta-blockers are generally contraindicated. The nurse should consult with the provider to ensure that Propranolol is the appropriate choice, as there may be safer alternatives to manage the client's condition without worsening their asthma.

Choice A rationale:

Prednisone is a corticosteroid commonly used to reduce inflammation and manage asthma exacerbations. It is an appropriate medication for asthma management and does not require clarification.

Choice B rationale:

Montelukast is a leukotriene receptor antagonist that is also used in the management of asthma. It helps to reduce airway inflammation and bronchoconstriction. Montelukast is an appropriate choice for asthma and does not need further clarification.

Choice C rationale:

Aminophylline is a bronchodilator that can be used in the treatment of asthma. While it may have potential side effects and interactions, it is not the first medication that needs clarification in this scenario. Propranolol, due to its potential to worsen asthma symptoms, takes precedence.